Table 3 Unadjusted and adjusted estimates of the association between SARS-CoV-2 IgG serostatus and pulmonary TB disease for each study and the combined dataset
From: SARS-CoV-2 infection and pulmonary tuberculosis in children and adolescents: a case-control study
Dataset | Participant group | SARS-CoV-2 IgG seropositive/ seronegative | Unadjusted OR (95% CI) | p-value | Adjusted ORa (95% CI) | p-value |
|---|---|---|---|---|---|---|
Teen TB | Non-TB controls | 31/20 | 1.0 | 1.0 | ||
TB cases | 23/27 | 0.55 (0.25–1.21) | 0.14 | 0.61 (0.21–1.77) | 0.84 | |
Umoya | Non-TB controls | 18/30 | 1.0 | - | ||
TB cases | 4/10 | 0.67 (0.18–2.44) | 0.54 | - | - | |
Combined | Non-TB controls | 49/50 | 1.0 | 1.0 | ||
TB cases | 27/37 | 0.74 (0.40–1.40) | 0.36 | 0.51 (0.23–1.11) | 0.09 |